Quick Answer
Black Diamond Therapeutics, Inc. reported Net Income of $22.37 million for fiscal year 2025.
Black Diamond Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $22.37M | +132.1% |
| 2024 | -$69.68M | +15.5% |
| 2023 | -$82.44M | +9.6% |
| 2022 | -$91.17M | +27.4% |
| 2021 | -$125.60M | -86.7% |
| 2020 | -$67.25M | -90.7% |
| 2019 | -$35.26M | -294.8% |
| 2018 | -$8.93M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.50M | +45.4% | +19.5% |
| June 30, 2025 | -$10.56M | +47.0% | -118.7% |
| March 31, 2025 | $56.54M | +410.2% | +463.5% |
| September 30, 2024 | -$15.56M | +32.4% | +21.9% |
| June 30, 2024 | -$19.91M | -4.0% | -9.2% |
| March 31, 2024 | -$18.23M | +12.7% | +20.8% |
| September 30, 2023 | -$23.01M | -6.2% | -20.1% |
| June 30, 2023 | -$19.15M | +16.5% | +8.3% |
- Black Diamond Therapeutics, Inc. showed an increase of +132.1% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Black Diamond Therapeutics, Inc.’s net income has grown by 350.4% (from -$8.93 million to $22.37 million).
- The most recent figure is from Black Diamond Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: